Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2010-02-04
2011-10-25
Kemmerer, Elizabeth C (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017200, C514S001100, C514S007600, C424S422000, C424S423000
Reexamination Certificate
active
08044026
ABSTRACT:
Provided herein are a composition for promoting cartilage formation or regeneration comprising a NELL gene product and a method of treating cartilage-related conditions using such a composition.
REFERENCES:
patent: 4394370 (1983-07-01), Jefferies
patent: 4409332 (1983-10-01), Jefferies et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5674725 (1997-10-01), Beertsen et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5846931 (1998-12-01), Hattersley et al.
patent: 5854207 (1998-12-01), Lee et al.
patent: 5916870 (1999-06-01), Lee et al.
patent: 5942496 (1999-08-01), Bonadio et al.
patent: 5948428 (1999-09-01), Lee et al.
patent: 6077987 (2000-06-01), Breitbart et al.
patent: 6083690 (2000-07-01), Harris et al.
patent: 6200606 (2001-03-01), Peterson et al.
patent: 6352972 (2002-03-01), Nimni et al.
patent: 6413998 (2002-07-01), Petrie et al.
patent: 6462019 (2002-10-01), Mundy et al.
patent: 7776361 (2010-08-01), Ting
patent: 7807787 (2010-10-01), Ting et al.
patent: 2003/0143688 (2003-07-01), Fujiwara et al.
patent: 2006/0053503 (2006-03-01), Culiat et al.
patent: WO 01/24821 (2001-04-01), None
patent: WO 2004/024893 (2004-03-01), None
Chiang et al., 2009, J. Formos. Med. Assoc. 108(2): 87-101.
Sun, 2010, Ann. New York Acad, Sci. 1211:37-50.
Aghaloo et al., “Nell-1-induced bone regeneration in calvarial defects”, Am. J. Pathol., vol. 169, pp. 903-915 (2006).
Barron et al., J. Am. Osteopath. Assoc. 107, pp. ES21-ES27 (2007).
Beck et al. “Rapid Publication TGF-β1Induces Bone Closure of Skull Defects.” J. ofBone Miner. Res. vol. 6, No. 11:1257-1265 (1991).
Bellows et al. “Determination of Numbers of Osteoprogenitors Present in Isolated Fetal Rat Calvaria Cells in Vitro.” Dev. Biol. 133, pp. 8-13 (1989).
Burger et al., “Osteoblast and Osteoclast Precursors in Primary Cultures of Calvarial Bone Cells.” Anat. Rec. Jan. 1986; 214(1): 32-40. Abstract only.
Chen et al. “Structure, Chromosomal Localization, and Expression Pattern of the MurineMagpGene,” J. Biol Chem. vol. 268, No, 36: 27381-27389 (1998).
Cowan et al., “Nell-1 induced bone formation within the distracted intermaxillary suture”, Bone, vol. 38, pp. 48-58 (2006).
Crawford et al. “Thrombospondin-1 is a Major Activator of TGF-β1in Vivo.” Cell, vol. 93:1159-1170 (1998).
Francois and Bier “Xenopus chordin and Drosophila short gastrulation Genes Encode Homologous Proteins Functioning in Dorsal-Ventral Axis Formation” Cell, vol. 80:19-20 (1995).
Gelbart, “Databases in Genomic Research” Science, vol. 282, Oct. 23, 1998.
Hoshi, K. et al., “Fibroblasts of Spinal Ligaments Pathologically Differentiate into Chondrocytes Induced by Recombinant Human Bone Morphogenetic Protein-2: Morphological Examinations for Ossification and Spinal Ligaments” Bone vol. 21, No. 2: 155-162 (1997).
International Search Report for PCT/US04/03808 filed Feb. 9, 2004, mailed Sep. 19, 2006, 9 pgs.
International Search Report for PCT/US2008/054779, mailed Aug. 1, 2008, 11 pgs.
Kim et al. “NELL-1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells.” Plastic Surgery, 599-601 (1999).
Kuroda and Tanizawa “Involvement of Epidermal Growth Factor-like Domain of NELL Proteins in the Novel Protein-Protein Interaction with Protein Kinase C1” Biochem Biophys Res. Commun. 265: 752-757 (1999).
Kuroda et al. “Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL1 and NELL2” Biochem Biophys Res Comm. 265: 79-86 (1999).
Liu et al., “Simultaneous Detection of Multiple Bone-Related mRNAs and Protein Expression during Osteoblast Differentiation: Polymerase Chain Reaction and Immunocytochemical Studies at the Single Cell Level”, Developmental Biology, vol. 166, pp. 220-234 (1994).
Lu et al., “The osteoinductive properties of Nell-1 in a rat spinal fusion model”, The Spine J. vol. 7, No. 1, pp. 50-60 (2007).
Luce and Burrows “The neuronal EGF-related genes NELL1 and NELL2 are expressed in hemopoietic cells and developmentally regulated in the B lineage”Gene231:121-126 (1999).
Opperman, et al., “TGF-β1, TGF- β2, and TGF-β3 Exhbit Distinct Patterns of Expression During Cranial Suture Formation and Obliteration in Vivo and in Vitro” J. of Bone and Mineral Research, vol. 12, No. 3: 301-310 (1997).
Piccolo et al. “Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4” Cell, vol. 86: 589-598 (1996).
Sins et al., “Design of NORA, the National Osteoporosis Risk Assessment program: A Longitudinal US Registry of Postmenopausal Women” Osteoporos Int. Suppl. 1: 62-69 (1998).
Takagi et al. “The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects” Ann Surg. vol. 196, No. 1: 100-109. Abstract only (1982).
Takami et al. “CA2+-ATPase Inhibitors and Ca2+-Ionophore Induce Osteoclast-like Cell Formation in the Cocultures of Mouse Bone Marrow Cells and Calvarial Cells” Biochemical and Biophysical Research Comm, vol. 237: 111-115 1997.
Tieu A. et al. “Identification of Human NEL-2 Associated with Premature Suture Fusion.” J Dent Res. 77(A):635, Abstract only (1998).
Ting et al. “Human NELL1 Expressed in Unilaterial Coronal Synostosis” J. of Bone and Mineral Res. vol. 14: 80-89 (1999).
Ting et al. “NEL-2 Expressed in Unilateral Prematurely Fusing and Fused Coronal Sutures.” J Dent Res. 77(B):2224 (1998) Abstract only.
Ting et al. “NEL-2 Gene is associated with bone formation in Craniosynostosis”, Plastic Surgery, 602-603 (no. date).
Ting et al. “NELL-1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells.”J. Dent. Res. 79:625 (2000).
Toriumi et al. “Mandibular Reconstruction With a Recombinant Bone-Inducing Factor.” Arch. Otolaryngol. Head Neck Surg. vol. 117: 1101-1112 (1991).
Watanabe, T.K. et al. “Cloning and Characterization of Two Novel Human cDNAs (NELL1 and NELL2) Encoding Proteins with Six EGF-like Repeats.” Genomics, vol. 38, 273-276 (1996).
Wobus, “Potential of embryonic stem cells” Molecular Aspects of Medicine (2001), 22/3 (149-164) (Abstract only) 1 pg.
Yasko et al. “The Healing of Segmental Bone Defects, Induced by Recombinant Human Bone Morphogenetic Protein (rhBMP-2).” J. of Bone and Joint Surgery vol. 74A, No. 5: 659-670 (1992).
Zhang et al., “Graniosynostosis in transgenic mice overexpressing Nell-1” The J. of Clinical Investigation, vol. 110, No. 6 (2002).
Zhang et al., “NELL-1 Overexpression Transgenic Mice Simulate Human Craniosynostosis”, Surgical Forum, vol. 52, pp. 576-578 (2001).
Soo Chia
Ting Kang
Wu Ben
Kemmerer Elizabeth C
Squire Sanders & Dempsey (US) LLP
The Regents of the University of California
LandOfFree
Composition for promoting cartilage formation or repair... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for promoting cartilage formation or repair..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for promoting cartilage formation or repair... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291110